333 related articles for article (PubMed ID: 19199928)
1. Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.
Shie FS; Nivison M; Hsu PC; Montine TJ
Curr Med Chem; 2009; 16(6):643-51. PubMed ID: 19199928
[TBL] [Abstract][Full Text] [Related]
2. Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease.
Shie FS; Woltjer RL
Curr Med Chem; 2007; 14(27):2865-71. PubMed ID: 18045132
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L
J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
Regen F; Hellmann-Regen J; Costantini E; Reale M
Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.
Landreth GE; Heneka MT
Neurobiol Aging; 2001; 22(6):937-44. PubMed ID: 11755002
[TBL] [Abstract][Full Text] [Related]
6. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
Webers A; Heneka MT; Gleeson PA
Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
[TBL] [Abstract][Full Text] [Related]
7. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
[TBL] [Abstract][Full Text] [Related]
8. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
9. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.
Medrano-Jiménez E; Jiménez-Ferrer Carrillo I; Pedraza-Escalona M; Ramírez-Serrano CE; Álvarez-Arellano L; Cortés-Mendoza J; Herrera-Ruiz M; Jiménez-Ferrer E; Zamilpa A; Tortoriello J; Pedraza-Alva G; Pérez-Martínez L
J Neuroinflammation; 2019 Jul; 16(1):143. PubMed ID: 31291963
[TBL] [Abstract][Full Text] [Related]
10. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
12. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
Bamberger ME; Landreth GE
Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease.
Fairley LH; Wong JH; Barron AM
Front Immunol; 2021; 12():624538. PubMed ID: 33717134
[TBL] [Abstract][Full Text] [Related]
14. Candesartan ameliorates brain inflammation associated with Alzheimer's disease.
Torika N; Asraf K; Apte RN; Fleisher-Berkovich S
CNS Neurosci Ther; 2018 Mar; 24(3):231-242. PubMed ID: 29365370
[TBL] [Abstract][Full Text] [Related]
15. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease.
Keaney J; Gasser J; Gillet G; Scholz D; Kadiu I
J Neuroimmune Pharmacol; 2019 Sep; 14(3):448-461. PubMed ID: 30758770
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of microglial activity as a therapy for Alzheimer's disease.
Tan B; Choi RH; Chin TJ; Kaur C; Ling EA
Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882
[TBL] [Abstract][Full Text] [Related]
18. A review: inflammatory process in Alzheimer's disease, role of cytokines.
Rubio-Perez JM; Morillas-Ruiz JM
ScientificWorldJournal; 2012; 2012():756357. PubMed ID: 22566778
[TBL] [Abstract][Full Text] [Related]
19. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
20. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]